State Of Wyoming Regenxbio Inc. Transaction History

State Of Wyoming

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$18.08 - $24.55 $22,527 - $30,589	-1,246 Reduced 50.34%	1,229 $23,000
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $28,927 - $35,067	-1,418 Reduced 36.42%	2,475 $56,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $60,272 - $94,748	2,704 Added 227.42%	3,893 $103,000
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $8,804 - $15,943	455 Added 61.99%	1,189 $29,000
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $6,081 - $8,474	247 Added 50.72%	734 $24,000

Q4 2021 Feb 11, 2022	BUY	$30.19 - $40.28 $2,083 - $2,779	69 Added 16.51%	487 $16,000
Q3 2021 Feb 11, 2022	SELL	$29.09 - $45.68 $8,668 - $13,612	-298 Reduced 41.62%	418 $18,000
Q2 2021 Feb 11, 2022	BUY	$32.46 - $40.48 $14,899 - $18,580	459 Added 178.6%	716 $28,000
Q1 2021 Feb 08, 2022	BUY	$33.61 - $49.95 $8,637 - $12,837	257 New	257 $9,000

193

42.6M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $622M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.